Replies to post #275474 on SwingTrade Member Forum (SWING)

[Steady_T]

All you Swing Trade Dickweeds, I'm letting you know that AVXL is coming up on a make or break event. They have a Parkinson's Dementia disease trial that will report in the next 2 to 6 weeks.

Avxl is a developmental stage biotech. So the risk is still there. IF the results come in good it is off to the races biotech style. The company has multiple other trials of the same drug for other central nervous system diseases underway. Including Alzheimer's, which has an OLE that is now going into its 5th year.

Ya pays ya money and ya takes ya chances. It's a biotech.

I own a boat load. Do your own DD to get a feel for the risk level.